External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study
Francesco Giuseppe Foschi, Fabio Conti, Marco Domenicali, P. Giacomoni, Alberto Borghi, Vittoria Bevilacqua, Lucia Napoli, Dante Berardinelli, Mattia Altini, Alessandro Cucchetti, Giorgio Ercolani, Andrea Casadei‐Gardini, Stefano Bellentani, Amalia Gastaldelli, Claudio Tiribelli, Giorgio Bedogni, Bagnacavallo Study Group
Abstract
We externally validated the fatty liver index (FLI), the lipid accumulation product (LAP), the hepatic steatosis index (HSI), and the Zhejiang University index (ZJU) for the diagnosis of fatty liver (FL) and non-alcoholic fatty liver disease (NAFLD) in the general population. The validation was performed on 2159 citizens of the town of Bagnacavallo (Ravenna, Italy). Calibration was evaluated by calculating the calibration slope and intercept and by inspecting calibration plots; discrimination was evaluated using the c-statistic. The average calibration slope was 1 and the average intercept was 0 for all combinations of outcomes and indices. For the diagnosis of FL, the c-statistic was 0.85 for FLI, 0.83 for ZJU, 0.82 for HSI, and 0.80 for LAP; for the diagnosis of NAFLD, the c-statistic was 0.77 for FLI, 0.76 for ZJU, 0.75 for HSI, and 0.74 for LAP. All indices were strongly correlated with each other. In conclusion, FLI, LAP, HSI, and ZJU perform similarly well to diagnose FL and NAFLD in the Bagnacavallo population, even if FLI has a small advantage as discrimination is concerned.